| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2022-03-07 02:51:38 UTC |
|---|
| HMDB ID | HMDB0014456 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Ethoxzolamide |
|---|
| Description | Ethoxzolamide is only found in individuals that have used or taken this drug. It is a carbonic anhydrase inhibitor used as diuretic and in glaucoma. It may cause hypokalemia. [PubChem]Ethoxzolamide binds and inhibits carbonic anhydrase I. Carbonic anhydrase plays an essential role in facilitating the transport of carbon dioxide and protons in the intracellular space, across biological membranes and in the layers of the extracellular space. The inhibition of this enzyme effects the balance of applicable membrane equilibrium systems. This reduction in carbonic anhydrase also reduces the intraocular pressure in the eye by decreasing aqueous humor. |
|---|
| Structure | CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13) |
|---|
| Synonyms | | Value | Source |
|---|
| 6-Ethoxy-2-benzothiazolesulfonamide | ChEBI | | 6-Ethoxy-benzothiazole-2-sulfonic acid amide | ChEBI | | 6-Ethoxybenzothiazole-2-sulfonamide | ChEBI | | Ethoxazolamide | ChEBI | | Ethoxyzolamide | ChEBI | | Cardrase | Kegg | | 6-Ethoxy-2-benzothiazolesulphonamide | Generator | | 6-Ethoxy-benzothiazole-2-sulfonate amide | Generator | | 6-Ethoxy-benzothiazole-2-sulphonate amide | Generator | | 6-Ethoxy-benzothiazole-2-sulphonic acid amide | Generator | | 6-Ethoxybenzothiazole-2-sulphonamide | Generator | | 6-Ethoxy-1,3-benzothiazole-2-sulfonamide | HMDB | | Etoxzolamide | HMDB | | Ethamide | HMDB |
|
|---|
| Chemical Formula | C9H10N2O3S2 |
|---|
| Average Molecular Weight | 258.317 |
|---|
| Monoisotopic Molecular Weight | 258.013283576 |
|---|
| IUPAC Name | 6-ethoxy-1,3-benzothiazole-2-sulfonamide |
|---|
| Traditional Name | ethoxzolamide |
|---|
| CAS Registry Number | 452-35-7 |
|---|
| SMILES | CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O |
|---|
| InChI Identifier | InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13) |
|---|
| InChI Key | OUZWUKMCLIBBOG-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzothiazoles. These are organic compounds containing a benzene fused to a thiazole ring (a five-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzothiazoles |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzothiazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,3-benzothiazole
- Alkyl aryl ether
- Organosulfonic acid amide
- Benzenoid
- Azole
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Thiazole
- Aminosulfonyl compound
- Heteroaromatic compound
- Ether
- Azacycle
- Organopnictogen compound
- Organic nitrogen compound
- Organosulfur compound
- Organic oxygen compound
- Organonitrogen compound
- Organic oxide
- Organooxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 189 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.69 g/L | Not Available | | LogP | 0.4 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.2 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.6386 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.22 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 28.5 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1869.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 402.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 150.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 243.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 133.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 423.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 603.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 114.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1044.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 406.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1144.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 329.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 364.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 370.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 264.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 98.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ethoxzolamide,1TMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N[Si](C)(C)C)SC2=C1 | 2399.1 | Semi standard non polar | 33892256 | | Ethoxzolamide,1TMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N[Si](C)(C)C)SC2=C1 | 2356.4 | Standard non polar | 33892256 | | Ethoxzolamide,1TMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N[Si](C)(C)C)SC2=C1 | 3370.4 | Standard polar | 33892256 | | Ethoxzolamide,2TMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)SC2=C1 | 2396.1 | Semi standard non polar | 33892256 | | Ethoxzolamide,2TMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)SC2=C1 | 2528.9 | Standard non polar | 33892256 | | Ethoxzolamide,2TMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N([Si](C)(C)C)[Si](C)(C)C)SC2=C1 | 3195.5 | Standard polar | 33892256 | | Ethoxzolamide,1TBDMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N[Si](C)(C)C(C)(C)C)SC2=C1 | 2652.9 | Semi standard non polar | 33892256 | | Ethoxzolamide,1TBDMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N[Si](C)(C)C(C)(C)C)SC2=C1 | 2606.7 | Standard non polar | 33892256 | | Ethoxzolamide,1TBDMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N[Si](C)(C)C(C)(C)C)SC2=C1 | 3393.1 | Standard polar | 33892256 | | Ethoxzolamide,2TBDMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)SC2=C1 | 2867.6 | Semi standard non polar | 33892256 | | Ethoxzolamide,2TBDMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)SC2=C1 | 2997.2 | Standard non polar | 33892256 | | Ethoxzolamide,2TBDMS,isomer #1 | CCOC1=CC=C2N=C(S(=O)(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)SC2=C1 | 3246.3 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Ethoxzolamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0fb9-1980000000-ec067e5e789b4033729a | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ethoxzolamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ethoxzolamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Ethoxzolamide LC-ESI-qTof , Positive-QTOF | splash10-0uk9-3900000000-26213ae94b481c876007 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ethoxzolamide , positive-QTOF | splash10-0uk9-3900000000-26213ae94b481c876007 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 10V, Positive-QTOF | splash10-0zfr-0960000000-30176db233c762327bb8 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 20V, Positive-QTOF | splash10-0fb9-0920000000-12f2a2d76e8d1872359c | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 40V, Positive-QTOF | splash10-067i-6900000000-150c9526ca35c5443818 | 2016-08-01 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 10V, Negative-QTOF | splash10-004i-4930000000-03953ab2f5340a6bde83 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 20V, Negative-QTOF | splash10-004i-5900000000-829e196c0d5d75dd73ba | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 40V, Negative-QTOF | splash10-0ufr-3910000000-a39e42db3eb1f695354e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 10V, Positive-QTOF | splash10-0a4i-0090000000-8af0d07ca07343f13e17 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 20V, Positive-QTOF | splash10-0a4i-0090000000-a6c40b0c6fafeaf3e12b | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 40V, Positive-QTOF | splash10-0fvi-1930000000-f047c1738e723ac089f7 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 10V, Negative-QTOF | splash10-004i-9150000000-98acc35e866c26644fd5 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 20V, Negative-QTOF | splash10-004i-9030000000-bb0adaec97d4ce4f9bd8 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ethoxzolamide 40V, Negative-QTOF | splash10-004i-9210000000-2862fcb806ab3f11f420 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|